Conversation with The Cancer Letter HHS seems poised to exert control over USPSTFRansohoff: The task force is the pinnacle of evidence-based medicine July 11, 2025Vol.51 No.27By Paul Goldberg
Guest Editorial Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities July 11, 2025Vol.51 No.27By Robert Peter Gale
Trials & Tribulations An overlooked immune cell population may offer new direction for cell and gene therapy July 11, 2025Vol.51 No.27By Arthur Machlenkin
Cancer Policy Supreme Court lifts lower-court freeze on RIFs July 11, 2025Vol.51 No.27By Jacquelyn Cobb
Cancer Policy House Dems host “The Things We’ll Never Know: A Science Fair of Canceled Grants” July 11, 2025Vol.51 No.27By Jacquelyn Cobb
Cancer Policy In the name of “radical transparency,” FDA touts publication of 200 complete response letters July 11, 2025Vol.51 No.27By Jacquelyn Cobb
Cancer Policy HHS asks employees to report instances of “DEI policies that caused discrimination” July 11, 2025Vol.51 No.27By Sara Willa Ernst
Cancer Policy Medical, cancer groups respond to Trump’s “Big Beautiful Bill” becoming law July 11, 2025Vol.51 No.27By Jacquelyn Cobb
In Brief Mary Beckerle to step down as CEO at Huntsman, succeeded by Brad Cairns July 11, 2025Vol.51 No.27
In Brief Kim Rhoads named associate director of community outreach and engagement VCU Massey July 11, 2025Vol.51 No.27
